Adaptive Biotechnologies vs Guardant Health
Adaptive Biotechnologies vs Guardant Health, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Guardant Health on 57/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 57/100
Guardant Health
- agent readiness: 51/100 against 39/100
- domain rating: 71/100 against 61/100
- funding raised: $900M against $300M
At a glance
| Measure | Adaptive Biotechnologies | Guardant Health |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Platform |
| Founded | 2009 | 2012 |
| Headquarters | Seattle, United States | Redwood City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Guardant Health |
|---|---|---|
| Employees | Not published | 4,663 |
| Total funding | $300M | $900M |
| Latest round | Series D | Post IPO |
| LinkedIn followers | Not published | 274,951 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Guardant Health |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 57/100 |
| Traction | Not published | 60/100 |
| Team | Not published | 10/100 |
| Search visibility | Not published | 33/100 |
| Quality | Not published | 70/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (51/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 71/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Guardant Health |
|---|---|---|
| Hosting | Self Managed | AWS |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Bootstrap |
| Analytics | Google Tag Manager | Google Analytics 4, Google Tag Manager, Microsoft Clarity |
Adaptive Biotechnologies vs Guardant Health: common questions
Which is better, Adaptive Biotechnologies or Guardant Health?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Guardant Health compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 57/100). Guardant Health leads on agent readiness (51/100 against 39/100), domain rating (71/100 against 61/100), funding raised ($900M against $300M).
Read the full Adaptive Biotechnologies review and pricing or the Guardant Health review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.